Kit Wong

1.1k total citations · 1 hit paper
9 papers, 716 citations indexed

About

Kit Wong is a scholar working on Physiology, Immunology and Allergy and Otorhinolaryngology. According to data from OpenAlex, Kit Wong has authored 9 papers receiving a total of 716 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Physiology, 6 papers in Immunology and Allergy and 3 papers in Otorhinolaryngology. Recurrent topics in Kit Wong's work include Asthma and respiratory diseases (8 papers), Allergic Rhinitis and Sensitization (6 papers) and Sinusitis and nasal conditions (3 papers). Kit Wong is often cited by papers focused on Asthma and respiratory diseases (8 papers), Allergic Rhinitis and Sensitization (6 papers) and Sinusitis and nasal conditions (3 papers). Kit Wong collaborates with scholars based in United States, Belgium and Spain. Kit Wong's co-authors include Philippe Gevaert, Joaquim Mullol, Theodore A. Omachi, Monet Howard, Claus Bachert, Monica Ligueros‐Saylan, Jonathan Corren, Lutaf Islam, Joseph K. Han and Stella E. Lee and has published in prestigious journals such as PLoS ONE, Journal of Allergy and Clinical Immunology and Allergy.

In The Last Decade

Kit Wong

9 papers receiving 702 citations

Hit Papers

Efficacy and safety of omalizumab in nasal polyposis: 2 r... 2020 2026 2022 2024 2020 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kit Wong United States 6 472 441 388 163 126 9 716
Aiko I. Klingler United States 8 388 0.8× 373 0.8× 446 1.1× 186 1.1× 60 0.5× 14 629
Jane Gilbert United Kingdom 6 261 0.6× 322 0.7× 251 0.6× 137 0.8× 99 0.8× 9 501
Ashraf Uzzaman United States 8 184 0.4× 215 0.5× 52 0.1× 56 0.3× 184 1.5× 9 521
Claus Bachert Germany 6 149 0.3× 194 0.4× 120 0.3× 105 0.6× 80 0.6× 14 349
S.M. Reinartz Netherlands 10 191 0.4× 205 0.5× 82 0.2× 82 0.5× 72 0.6× 19 348
Shintaro Baba Japan 10 155 0.3× 196 0.4× 154 0.4× 87 0.5× 30 0.2× 30 339
Zhi Bin Lin China 11 134 0.3× 145 0.3× 89 0.2× 103 0.6× 49 0.4× 17 324
Cailong Fang United Kingdom 6 200 0.4× 508 1.2× 13 0.0× 133 0.8× 166 1.3× 7 735
Kęstutis Malakauskas Lithuania 14 80 0.2× 311 0.7× 13 0.0× 89 0.5× 172 1.4× 52 460
H. Luckhaupt Germany 8 62 0.1× 60 0.1× 146 0.4× 145 0.9× 64 0.5× 32 309

Countries citing papers authored by Kit Wong

Since Specialization
Citations

This map shows the geographic impact of Kit Wong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kit Wong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kit Wong more than expected).

Fields of papers citing papers by Kit Wong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kit Wong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kit Wong. The network helps show where Kit Wong may publish in the future.

Co-authorship network of co-authors of Kit Wong

This figure shows the co-authorship network connecting the top 25 collaborators of Kit Wong. A scholar is included among the top collaborators of Kit Wong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kit Wong. Kit Wong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Le, Kha, et al.. (2023). PK/PD modeling to characterize placebo and treatment effect of omalizumab for chronic spontaneous urticaria. CPT Pharmacometrics & Systems Pharmacology. 12(6). 795–807. 4 indexed citations
2.
Zhu, Rui, Ryan Owen, Justin Wilkins, et al.. (2021). Pharmacokinetics and exposure-efficacy relationships of omalizumab in patients with nasal polyps. Pulmonary Pharmacology & Therapeutics. 71. 102080–102080. 2 indexed citations
3.
Gevaert, Philippe, et al.. (2021). The Role of IgE in Upper and Lower Airway Disease: More Than Just Allergy!. Clinical Reviews in Allergy & Immunology. 62(1). 200–215. 33 indexed citations
4.
Gevaert, Philippe, Jonathan Corren, Joseph K. Han, et al.. (2021). Long-term efficacy and safety of omalizumab for nasal polyposis in an open-label extension study. Journal of Allergy and Clinical Immunology. 149(3). 957–965.e3. 85 indexed citations
5.
Gevaert, Philippe, Theodore A. Omachi, Jonathan Corren, et al.. (2020). Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials. Journal of Allergy and Clinical Immunology. 146(3). 595–605. 453 indexed citations breakdown →
6.
Bachert, Claus, Philippe Gevaert, Jonathan Corren, et al.. (2020). Omalizumab Improves Outcomes in Patients with Chronic Rhinosinusitis with Nasal Polyps Irrespective of Asthma Status. Journal of Allergy and Clinical Immunology. 145(2). AB149–AB149. 4 indexed citations
7.
Rhee, Rennie L., Cécile Holweg, Kit Wong, et al.. (2018). Serum periostin as a biomarker in eosinophilic granulomatosis with polyangiitis. PLoS ONE. 13(10). e0205768–e0205768. 9 indexed citations
8.
Doran, Emma, Fang Cai, Cécile Holweg, et al.. (2017). Interleukin-13 in Asthma and Other Eosinophilic Disorders. Frontiers in Medicine. 4. 139–139. 102 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026